Publikace
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | 1. lékařská fakulta
- BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas2020 | 1. lékařská fakulta
- Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study2020 | 1. lékařská fakulta
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | 1. lékařská fakulta, 2. lékařská fakulta
- Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL2019 | 1. lékařská fakulta
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma2016 | 1. lékařská fakulta, 2. lékařská fakulta
- Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells2015 | 1. lékařská fakulta
- Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research2014 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents2014 | 1. lékařská fakulta
- Roscovitin senzitizuje leukemické a lymfomové buňky na TRAIL2013 | Ústřední knihovna, 1. lékařská fakulta
Loading network view...